FIRST MIDWEST BANK TRUST DIVISION - INTELLIPHARMACEUTICS INTL IN ownership

INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 21 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q1 2014. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
FIRST MIDWEST BANK TRUST DIVISION ownership history of INTELLIPHARMACEUTICS INTL IN
ValueSharesWeighting
Q3 2015$29,000
-79.1%
16,120
-65.8%
0.01%
-77.3%
Q2 2015$139,000
+5.3%
47,1520.0%0.02%
+10.0%
Q1 2015$132,000
+25.7%
47,152
+1.0%
0.02%
+25.0%
Q4 2014$105,000
-29.5%
46,672
-5.5%
0.02%
-33.3%
Q3 2014$149,000
-19.0%
49,372
+2.1%
0.02%
-17.2%
Q2 2014$184,000
-10.2%
48,342
+3.5%
0.03%
-12.1%
Q1 2014$205,00046,6920.03%
Other shareholders
INTELLIPHARMACEUTICS INTL IN shareholders Q1 2014
NameSharesValueWeighting ↓
FIRST FOUNDATION ADVISORS 594,953$589,0000.03%
Argent Trust Co 59,693$59,0000.02%
Verity Asset Management, Inc. 30,000$28,0000.02%
A.R.T. Advisors, LLC 52,822$52,0000.00%
Advisor Group, Inc. 56,469$56,0000.00%
TWO SIGMA SECURITIES, LLC 15,601$15,0000.00%
IFP Advisors, Inc 13$00.00%
GEODE CAPITAL MANAGEMENT, LLC 13,756$13,0000.00%
FNY Managed Accounts LLC 1,000$00.00%
Financial Architects, Inc 2,000$2,0000.00%
View complete list of INTELLIPHARMACEUTICS INTL IN shareholders